Ottawa Hospital Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 2001-01-01

Employees: 5K

Market Cap: -

Website: http://www.ohri.ca

Clinical Trials

Bone Mineral Density (BMD) in Cemented Versus Cementless Hip Resurfacing

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Device: Conserve
Device: Cormet

First Posted Date: 2011-05-13

Last Posted Date: 2018-04-02

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 120

Registration Number: NCT01353326

Locations: 🇨🇦
Ottawa General Hospital, Ottawa, Ontario, Canada

Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study

Phase 4

Completed

Conditions: Disease Due to BK Polyomavirus
Kidney Transplant Infection

Interventions: Drug: Levofloxacin

First Posted Date: 2011-05-13

Last Posted Date: 2024-04-05

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 154

Registration Number: NCT01353339

Locations: 🇨🇦
Capital Health - University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦
Winnipeg Health Science Center, Winnipeg, Manitoba, Canada
🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada

and more 8 locations

Evaluation of the Nursing C-Spine (Phase IV)

Phase 4

Completed

Conditions: Fracture of Cervical Spine
Fracture Dislocation of Cervical Spine

Interventions: Other: Clinical decision rule - clearing the c-spine

First Posted Date: 2011-05-13

Last Posted Date: 2011-05-13

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 3633

Registration Number: NCT01353352

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit

Completed

Conditions: HIV Infections

First Posted Date: 2011-04-29

Last Posted Date: 2011-04-29

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 40

Registration Number: NCT01344642

Locations: 🇨🇦
The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada

Creating a Tissue Bank of Knee Capsules

Withdrawn

Conditions: Osteoarthritis
Knee Joint Contractures

First Posted Date: 2011-03-22

Last Posted Date: 2015-04-23

Lead Sponsor: Ottawa Hospital Research Institute

Registration Number: NCT01320124

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Kidney Transplant Failure

Terminated

Conditions: Acute Graft Rejection
Renal Failure Chronic Requiring Dialysis

First Posted Date: 2011-02-15

Last Posted Date: 2019-09-06

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 270

Registration Number: NCT01296061

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

IXO+A in mCRC With Liver-only Metastases

Phase 2

Withdrawn

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab

First Posted Date: 2011-02-11

Last Posted Date: 2013-06-05

Lead Sponsor: Ottawa Hospital Research Institute

Registration Number: NCT01293942

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦
McGill University Health Centre, Montreal, Quebec, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

and more 1 locations

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot

Phase 3

Completed

Conditions: Postpartum
Venous Thromboembolism

Interventions: Drug: Dalteparin Sodium

First Posted Date: 2011-01-11

Last Posted Date: 2017-08-01

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 62

Registration Number: NCT01274637

Locations: 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
🇺🇸
Puget Sound Blood Center, Seattle, Washington, United States
🇨🇦
McMaster University Medical Centre, Hamilton, Ontario, Canada

and more 4 locations

Weaning And Variability Evaluation

Completed

Conditions: Mechanically Ventilated Patients
Extubation

First Posted Date: 2010-11-10

Last Posted Date: 2017-07-07

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 660

Registration Number: NCT01237886

Locations: 🇺🇸
The University of Michigan Medical Center, Ann Arbor, Michigan, United States
🇺🇸
Columbia University, New York, New York, United States
🇺🇸
Intermountain Medical Center/University of Utah School of Medicine, Salt Lake City, Utah, United States

and more 11 locations

IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer

Phase 2

Conditions: Rectal Cancer

Interventions: Drug: IXO regimen

First Posted Date: 2010-11-09

Last Posted Date: 2012-10-15

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 15

Registration Number: NCT01237665

Locations: 🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy